Goldman Sachs
CLX icon

Goldman Sachs’s Clorox CLX Stock Holding History

Goldman Sachs’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,600
Closed -$2.09M – 6255
2021
Q2 		$2.09M Sell
11,600
-2,800
-19% -$511K ﹤0.01% 4162
2021
Q1 		$2.78M Buy
+14,400
New +$2.77M ﹤0.01% 3657
2019
Q1 		– Sell
-26,100
Closed -$4.02M – 5173
2018
Q4 		$4.02M Sell
26,100
-40,600
-61% -$6.32M ﹤0.01% 3059
2018
Q3 		$10M Buy
+66,700
New +$9.48M ﹤0.01% 2458
2018
Q2 		– Sell
-1,200
Closed -$160K – 5694
2018
Q1 		$160K Sell
1,200
-2,400
-67% -$322K ﹤0.01% 5101
2017
Q4 		$535K Sell
3,600
-300
-8% -$40.8K ﹤0.01% 4770
2017
Q3 		$514K Buy
3,900
+1,300
+50% +$175K ﹤0.01% 5064
2017
Q2 		$346K Sell
2,600
-3,900
-60% -$526K ﹤0.01% 5382
2017
Q1 		$876K Sell
6,500
-3,500
-35% -$453K ﹤0.01% 4499
2016
Q4 		$1.2M Buy
10,000
+2,000
+25% +$236K ﹤0.01% 4286
2016
Q3 		$1M Sell
8,000
-700
-8% -$91.7K ﹤0.01% 4397
2016
Q2 		$1.2M Buy
8,700
+3,900
+81% +$506K ﹤0.01% 4043
2016
Q1 		$605K Sell
4,800
-13,800
-74% -$1.75M ﹤0.01% 4560
2015
Q4 		$2.36M Sell
18,600
-3,800
-17% -$472K ﹤0.01% 3482
2015
Q3 		$2.59M Buy
22,400
+8,800
+65% +$988K ﹤0.01% 3532
2015
Q2 		$1.42M Sell
13,600
-14,000
-51% -$1.51M ﹤0.01% 4202
2015
Q1 		$3.05M Sell
27,600
-215,600
-89% -$23.4M ﹤0.01% 3375
2014
Q4 		$25.3M Buy
243,200
+130,700
+116% +$13.1M 0.01% 1656
2014
Q3 		$10.8M Buy
112,500
+77,300
+220% +$6.99M ﹤0.01% 2299
2014
Q2 		$3.22M Sell
35,200
-13,400
-28% -$1.2M ﹤0.01% 3498
2014
Q1 		$4.28M Sell
48,600
-37,700
-44% -$3.31M ﹤0.01% 3197
2013
Q4 		$8.01M Sell
86,300
-79,900
-48% -$7.2M ﹤0.01% 2581
2013
Q3 		$13.6M Buy
166,200
+8,100
+5% +$684K 0.01% 1943
2013
Q2 		$13.1M Buy
+158,100
New +$13.6M 0.01% 1854

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs's CLX Position: Q2 2026 in Review

Goldman Sachs reduced its Clorox (CLX) stake by 13% in Q2 2026, selling an estimated $16M and leaving 1,092,055 shares worth $104M. The position accounts for 0.01% of the portfolio, ranked #1195.

Goldman Sachs first reported a position in CLX in Q2 2013 and has held it in 53 quarters since. The position peaked at $210M in Q1 2020. 1,046 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Goldman Sachs held 1,092,055 shares of Clorox worth $104M as of Q2 2026.
  • Goldman Sachs sold 166,541 Clorox shares in Q2 2026, an estimated $16M.
  • Clorox made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1195 holding.
  • Goldman Sachs first reported a position in Clorox in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Clorox position peaked at $210M in Q1 2020.
  • 1,046 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.